Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Hormone Refractory Prostate Cancer”

1,105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,105 results

Early research (Phase 1)Study completedNCT04179396
What this trial is testing

Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 8
Testing effectiveness (Phase 2)Looking for participantsNCT06288113
What this trial is testing

Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Jonsson Comprehensive Cancer Center 40
Not applicableStudy completedNCT02353715
What this trial is testing

Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing

Who this might be right for
Prostate Cancer
Duke University 38
Not applicableStudy completedNCT02380274
What this trial is testing

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerMetastatic Prostate Cancer
Astellas Pharma Global Development, Inc. 1,030
Early research (Phase 1)Study completedNCT01385228
What this trial is testing

Pazopanib, Docetaxel, Prednisone Prostate

Who this might be right for
Prostate Cancer
Daniel George, MD 36
Testing effectiveness (Phase 2)Ended earlyNCT00176527
What this trial is testing

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Medicine and Dentistry of New Jersey 40
Testing effectiveness (Phase 2)Looking for participantsNCT07142551
What this trial is testing

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Large-scale testing (Phase 3)Study completedNCT00116142
What this trial is testing

Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 350
Testing effectiveness (Phase 2)Ended earlyNCT02933801
What this trial is testing

ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.

Who this might be right for
Prostate Cancer MetastaticProstate Cancer
Swiss Cancer Institute 92
Testing effectiveness (Phase 2)Looking for participantsNCT05720130
What this trial is testing

Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
AdvanCell Pty Limited 100
Testing effectiveness (Phase 2)Study completedNCT02788773
What this trial is testing

Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Canadian Cancer Trials Group 52
Early research (Phase 1)Active Not RecruitingNCT03845166
What this trial is testing

XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Who this might be right for
Neoplasm MalignantRenal Cell CarcinomaHormone Receptor Positive Breast Carcinoma+2 more
Exelixis 325
Large-scale testing (Phase 3)Study completedNCT01605227
What this trial is testing

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Who this might be right for
Prostate CancerCastration Resistant Prostate CancerPain+1 more
Exelixis 1,028
Early research (Phase 1)WithdrawnNCT02182622
What this trial is testing

LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel

Who this might be right for
Prostate Cancer
Martin Gutierrez
Testing effectiveness (Phase 2)WithdrawnNCT00003622
What this trial is testing

Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Who this might be right for
Prostate Cancer
James Ahlgren
Testing effectiveness (Phase 2)Study completedNCT01074138
What this trial is testing

Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Bone-Metastatic, Castration-Resistant Prostate Cancer
Athenex, Inc. 31
Early research (Phase 1)Study completedNCT04397276
What this trial is testing

JNJ-70218902 in Participants With Advanced Stage Solid Tumors

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 82
Testing effectiveness (Phase 2)Study completedNCT03554317
What this trial is testing

COMbination of Bipolar Androgen Therapy and Nivolumab

Who this might be right for
Castration-resistant Prostate CancerMetastatic Prostate CancerProstate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45
Early research (Phase 1)Study completedNCT03136640
What this trial is testing

ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Modra Pharmaceuticals 23
Testing effectiveness (Phase 2)Looking for participantsNCT06866938
What this trial is testing

Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Hospices Civils de Lyon 58
Load More Results